经皮冠状动脉介入治疗在当代慢性冠脉综合征管理中的作用
综述指出,当代随机试验显示PCI与保守策略在全因死亡或心肌梗死方面无差异,但试验缺乏单个终点把握度且需长期随访。开放标签试验一致显示PCI改善稳定心绞痛症状和生活质量。在严重左室收缩功能障碍合并阻塞性冠心病患者中,PCI未改善全因死亡、心衰住院或左室功能恢复,但未增加风险。
要点
- PCI与保守策略在全因死亡或心肌梗死方面无差异,但试验把握度不足。
- 开放标签试验显示PCI改善稳定心绞痛患者的症状和生活质量。
- 严重左室收缩功能障碍患者中PCI未改善硬终点但未增加风险,仍为治疗选择。
核心结论
- 当代随机试验未显示PCI较保守策略降低全因死亡或心肌梗死,但试验缺乏单个终点把握度且需长期随访。
- 开放标签试验一致显示PCI改善稳定心绞痛症状和生活质量。
- 严重左室收缩功能障碍合并阻塞性冠心病患者中,PCI未改善全因死亡、心衰住院或左室功能恢复,但未增加风险。
研究设计与样本
- 本文为综述,汇总当代随机试验和荟萃分析证据,提供批判性解读框架。
- 涉及Revascularization for Ischemic Ventricular Dysfunction试验等。
主要发现
- PCI与保守策略在全因死亡或心肌梗死方面无差异。
- 开放标签试验显示PCI改善症状和生活质量。
- 严重左室收缩功能障碍患者中PCI未改善全因死亡、心衰住院或左室功能恢复。
- 多数患者报告无心绞痛,随机PCI试验中心绞痛负担低是广泛引用的局限性。
临床怎么用
- 症状控制不佳时PCI仍是重要策略,应通过适当患者选择最大化其价值。
- 严重左室收缩功能障碍患者中,PCI在有利患者特征时仍为治疗选择。
局限性
- 试验缺乏单个终点把握度,需长期随访数据。
- 随机PCI试验中心绞痛负担低是广泛引用的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Contemporary randomised trials of percutaneous coronary intervention (PCI) in chronic coronary syndrome (CCS) demonstrate no difference between patients treated with a conservative or invasive strategy with respect to all-cause mortality or myocardial infarction, although trials lack power to test for individual endpoints and long-term follow-up data are needed. Open-label trials consistently show greater improvement in symptoms and quality of life among patients with stable angina treated with PCI. Further studies are awaited to clarify this finding. In patients with severe left ventricular (LV) systolic dysfunction and obstructive coronary artery disease in the Revascularization for Ischemic Ventricular Dysfunction trial, PCI has not been found to improve all-cause mortality, heart failure hospitalisation or recovery of LV function when compared with medical therapy. PCI was, however, performed without additional hazard and so remains a treatment option when there are favourable patient characteristics. The majority of patients reported no angina, and the low burden of angina in many of the randomised PCI trials is a widely cited limitation. Despite contentious evidence, elective PCI for CCS continues to play a significant role in UK clinical practice. While PCI for urgent indications has more than doubled since 2006, the rate of elective PCI remains unchanged. PCI remains an important strategy when symptoms are not well controlled, and we should maximise its value with appropriate patient selection. In this review, we provide a framework to assist in critical interpretation of findings from most recent trials and meta-analysis evidence.
引用
- Cartlidge T, Kovacevic M, Navarese EP, et al. Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome. Heart. 2023. PMID: 36928242. doi:10.1136/heartjnl-2022-321870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。